Strados Labs returned to the Respiratory Innovation Summit (RIS), taking place at ATS 2024 in San Diego, CA where Strados was also an exhibitor (Booth 1131). RIS took place from May 17-18. Hosted by the American Thoracic Society, the Respiratory Innovation Summit...
24-hour cough frequency has traditionally been recognized as the ‘gold standard’ primary endpoint for indications such as refractory chronic cough, chronic bronchitis, and IPF-related cough. While frequency is undoubtedly a valuable metric to measure for cough, there...
In December 2023, the FDA published its final release of “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations” a pivotal step in formalizing regulatory standards and guidance for remote data collection in clinical trials. As the...
We are thrilled to announce that through our various partnerships with life sciences organizations, Strados Labs has successfully captured a staggering 10 million breaths in this year alone - and counting! This milestone marks a significant step towards advancing...
Strados Labs’ RESP™ Biosensor is currently being used in a clinical trial at Lurie Children’s to determine if the technology can accurately detect wheezing and other symptoms of asthma exacerbation in children. PHILADELPHIA, PA – September 26th, 2023 – Strados...
